Last10K.com

Advansource Biomaterials Corp (ASNB) SEC Filing 8-K Material Event for the period ending Tuesday, August 22, 2017

Advansource Biomaterials Corp

CIK: 1011060 Ticker: ASNB

View differences made from one to another to evaluate Advansource Biomaterials Corp's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Advansource Biomaterials Corp.

Continue

Assess how Advansource Biomaterials Corp's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Advansource Biomaterials Corp's Definitive Proxy Statement (Form DEF 14A) filed after their 2017 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

Tools

Material Contracts, Statements, Certifications & more

Advansource Biomaterials Corp provided additional information to their SEC Filing as exhibits

Ticker: ASNB
CIK: 1011060
Form Type: 8-K Corporate News
Accession Number: 0001011060-17-000026
Submitted to the SEC: Tue Aug 22 2017 10:03:43 AM EST
Accepted by the SEC: Tue Aug 22 2017
Period: Tuesday, August 22, 2017
Industry: Surgical And Medical Instruments And Apparatus
Events:
  1. Event for Officers
  2. Financial Exhibit

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/asnb/0001011060-17-000026.htm